PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome

PITTSBURGH, Jan. 13, 2022 -- (Healthcare Sales & Marketing Network) -- PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distributi... Biopharmaceuticals, Distribution Xeris Pharmaceuticals, PANTHERx Rare, Recorlev, levoketoconazole, Cushing's
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news